ZYBT
Zhengye Biotechnology Holding Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$1.42
+5.97%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.13x
- Price / sales
- 1.98x
- Price / cash flow
- 14.57x
Enterprise value
- Enterprise value
- $54.2M
- EV / sales
- 2.54x
- EV / EBITDA
- -6.24x
- EV / EBIT
- -4.00x
- Market cap
- $42.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025